covid19

The COVID-19 rapid antibody test, developed by Abingdon Health, the medical device manufacturer leading the UK-Rapid Test Consortium (UK-RTC), has received its CE mark. This means it is approved for professional use in the UK and EU.

This milestone means the rapid test, for detection of IgG antibodies to the SARS-CoV-2 virus (COVID-19) is now available for distribution for professional use. It will be mass produced and tests will be rolled out from the end of August. The test can be administered by healthcare professionals, such as doctors, nurses, pharmacists and healthcare workers.

Following production of tens of thousands of tests across multiple production scale batches the test has been shown to be 99.40% accurate. Testing was performed at the Ulster University and at the laboratories of Abingdon Health.

The test will be named the “AbC-19 Rapid Test”.  It uses a small drop of blood from a finger-prick, and shows results in 20 minutes, without the need to send a sample to a lab. To understand how the test works, Abingdon Health has released a new video: www.youtube.com/watch?v=WqT2z8jCEHs.  

https://www.clinicalservicesjournal.com/story/33350/uk-covid-19-rapid-antibody-tests-are-approved-for-professional-use